Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
32
33
Next >
Immunome - Oncology Is Hot
January 10, 2024
Tickers
IMNM
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Chart Of The Day: Elanco Animal Health- Big Money In Animal Pharma
January 10, 2024
Tickers
ELAN
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
MicroMarvet - Fulcrum Therapeutics - Confusing Projections And Recommendation
January 09, 2024
Tickers
FULC
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
Chart Of The Day: Innoviva - Individual Investor Favorite
January 08, 2024
Tickers
INVA
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
3 Top Biotech Stocks Worth Adding To Your Portfolio In 2024
January 07, 2024
Tickers
BGNE
REGN
SRPT
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Week In Review: 2024 Kicks Off With Three Deals Worth A Total Of $4 Billion
January 07, 2024
Tickers
APLM
BNTX
NVS
RHHBY
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
A Rough Start To 2024 What Might Be In Store For The Rest Of 2024?
January 07, 2024
Tickers
AMGN
GLD
IBB
KRE
Tags
Gold/Precious Metals
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Stifel: ‘Party Is Just Getting Started’ In This Stock That's Up 80%
January 07, 2024
Tickers
ELAN
IDXX
ZTS
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
More Than 140 Drug Brands Will Have Their Prices Hiked Heading Into 2024
January 04, 2024
Tickers
GSK
PFE
SNY
TAK
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Has The Rally Lost Steam? Price, Momentum, And Volume Hold The Clues!
January 03, 2024
Tickers
CRWD
JPM
LOGI
SPX
Tags
Gold/Precious Metals
Communications
Services
From
TalkMarkets
Week In Review: $1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal
December 31, 2023
Tickers
ALPMY
AZN
GRCL
IVBXF
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Government-granted Patent Monopolies Are Not The Free Market
December 29, 2023
Tickers
BIIB
PJP
PPH
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
AI-Focused Drug Discovery Stocks Index Up 26% In December
December 29, 2023
Tickers
ABCL
ABSI
BTAI
EXAI
Tags
Healthcare
Technology
Stocks / Equities
From
TalkMarkets
APM Stock: Is It Worth Investing In APM?
December 29, 2023
Tickers
APM
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Psychedelic Drug Stocks Index Up In December; Down YTD
December 27, 2023
Tickers
ATAI
CMPS
GHRS
IXHL
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Small Caps Are On A Tear Including Speculative Biotechs
December 26, 2023
Tickers
ABBV
ARKG
CPRX
HOLX
Tags
ETFs
Healthcare
Pharma/Biotech
From
TalkMarkets
3 Reasons Why Amphastar Is a Great Growth Stock
December 26, 2023
Tickers
AMPH
Tags
Stocks / Equities
Market News
Pharma/Biotech
From
TalkMarkets
Bristol-Myers Buying Karuna Signals A Biotech Boom Ahead: Jefferies
December 24, 2023
Tickers
BMY
KRTX
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Thoughts For Thursday: Everything That Goes Up Comes Down
December 21, 2023
Tickers
F
LUV
PFE
TSLA
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Canopy Growth: What Next For The Vulnerable CGC Stock?
December 20, 2023
Tickers
CGC
YOLO
Tags
Healthcare
Stocks / Equities
Market News
From
TalkMarkets
Long-Term, Organic Revenue Growth Is A Key To Investment Success
December 20, 2023
Tickers
MRNA
PTEN
ZM
Tags
Energy
Financial
Communications
From
TalkMarkets
AI-Focused Drug Discovery Stocks Index Up 10.6% Last Week
December 17, 2023
Tickers
ABCL
ABSI
BTAI
EXAI
Tags
Technology
Stocks / Equities
Market News
From
TalkMarkets
Psychedelic Drug Stocks Index Declined 1.6% This Week
December 17, 2023
Tickers
ATAI
CMPS
GHRS
IXHL
Tags
ETFs
Stocks / Equities
Market News
From
TalkMarkets
Moderna Entering Weekly Bluebox Support Area
December 17, 2023
Tickers
MRNA
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
Compass Pathways: A Higher-Risk But Potentially Higher-Reward Company In The Biotech Arena
December 16, 2023
Tickers
CMPS
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Chart Of The Day: Does Blueprint Medicines Have A Blueprint For Success?
December 13, 2023
Tickers
BPMC
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Tuesday Talk: CPI Data And FOMC Meeting Hold Back Market Breakout
December 12, 2023
Tickers
AVGO
BIIB
CI
DIA
Tags
Consumer Goods
Technology
Pharma/Biotech
From
TalkMarkets
Biotech Is Coming Back, Can The Run Last?
December 11, 2023
Tickers
ABBV
BIIB
IBB
LLY
Tags
Healthcare
ETFs
Stocks / Equities
From
TalkMarkets
The 10 Stocks Using AI To Develop New Drugs Were Up 4%, On Average, Last Week
December 11, 2023
Tickers
ABCL
ABSI
EXAI
RLAY
Tags
Pharma/Biotech
Market News
Stocks / Equities
From
TalkMarkets
5 Largest Psychedelic Compound-Based Drug Stocks Up 3% Last Week
December 10, 2023
Tickers
ATAI
CMPS
GHRS
IXHL
Tags
ETFs
Pharma/Biotech
Market News
From
TalkMarkets
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.